Login to Your Account

Financings Roundup

Thursday, January 13, 2011
CytRx Corp., of Los Angeles, sold its remaining equity interest in RXi Pharmaceuticals Corp., of Worcester, Mass., raising $7 million to support advancement of its oncology pipeline into the clinic.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription